HLA-DMA anticorps (AA 1-261)

N° du produit ABIN1327535

Détail du produit anti-HLA-DMA anticorps

Antigène: HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))

Épitope: AA 1-261

Reactivité: Humain

Hôte: Souris

Clonalité: Polyclonal

Conjugué: Cet anticorp HLA-DMA est non-conjugé

Application: Western Blotting (WB)

Fonction: Mouse polyclonal antibody raised against a full-length human HLA-DMA protein.

Séquence: MGHEQNQGAA LLQMLPLLWL LPHSWAVPEA PTPMWPDDLQ NHTFLHTVYC QDGSPSVGLS EAYDEDQLFF FDFSQNTRVP RLPEFADWAQ EQGDAPAILF DKEFCEWMIQ QIGPKLDGKI PVSRGFPIAE VFTLKPLEFG KPNTLVCFVS NLFPPMLTVN WQHHSVPVEG FGPTFVSAVD GLSFQAFSYL NFTPEPSDIF SCIVTHEIDR YTAIAYWVPR NALPSDLLEN VLCGVAFGLG VLGIIVGIVL IIYFRKPCSG D

Réactivité croisée: Humain

Attributs du produit: Antibody reactive against mammalian transfected lysate.

Immunogène: HLA-DMA (NP_006111.2, 1 a.a. ~ 261 a.a) full-length human protein.

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: In 1x PBS, pH 7.4

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Détails sur HLA-DMA

Antigène: HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))

Autre désignation: HLA-DMA (HLA-DMA Produits)

Synonymes: anticorps RT1.Ma, anticorps RT1.DMa, anticorps HLA-DMA, anticorps H-2Ma, anticorps H2-Ma, anticorps D6S222E, anticorps DMA, anticorps HLADM, anticorps RING6, anticorps RT1 class II, locus DMa, anticorps SLA-DM alpha chain, anticorps major histocompatibility complex, class II, DM alpha, anticorps histocompatibility 2, class II, locus DMa, anticorps RT1-DMa, anticorps SLA-DMA, anticorps DLA-DMA, anticorps H2-DMa, anticorps HLA-DMA

Sujet: Full Gene Name: major histocompatibility complex, class II, DM alpha
Synonyms: D6S222E,DMA,HLADM,RING6

ID gène: 3108

NCBI Accession: NM_006120

Pathways: Cancer Immune Checkpoints